Page
%P
-
Article
A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with several antigenic variants, has grown into a global challenge, and the rapid establishment of an immune barrier is crucial to achieving long-t...